KaloBios Pharmaceuticals Inc (NASDAQ:KBIO)

Data as of Jan 29
 +0.0038 / +0.92%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Revenue and IncomeNet Revenues17.7M20.3M6.1M44.0K
Operating ExpensesGross Income16.9M19.7M5.8M--
Total Operating Expenses23.8M21.4M29.6M41.0M
Non-Operating ExpensesOperating Income-6.1M-1.2M-23.5M-40.9M
Extraordinary Credit2.0K0.000.000.00
Extraordinary Charge0.00-1.1M-39.0K0.00
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.1M-2.2M-23.5M-41.9M
Net Income-5.1M-2.2M-23.5M-41.9M
Shares To Calculate EPSShares To Calculate EPS24.1M24.1M2.1M24.3M
Shares To Calculate EPS Diluted24.1M24.1M2.1M24.3M
Earnings Per ShareEPS-$3.02-$1.15-$11.22-$1.73
EPS Diluted----------

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.